Innate Pharma H1每股收益（0.28）同比上升（0.34）美元，销售额从同比1，335万美元下降551万美元

Innate Pharma (NASDAQ: IPHA) reported quarterly losses of $(0.28) per share. This is a 16.76 percent increase over losses of $(0.34) per share from the same period last year. The company reported $5.51 million in sales this quarter. This is a 58.72 percent decrease over sales of $13.35 million the same period last year.